We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-18.27%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$170B
AUM Growth
-$15.8B
Cap. Flow
+$31.1B
Cap. Flow %
18.26%
Top 10 Hldgs %
16.53%
Holding
3,284
New
103
Increased
2,418
Reduced
437
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Healthcare 13.41%
3 Financials 11.59%
4 Industrials 9.19%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMNB
2626
DELISTED
American National Bankshares Inc
AMNB
$643K ﹤0.01%
26,885
-777
-3% -$25.3K
ACTG icon
2627
Acacia Research
ACTG
$470M
$639K ﹤0.01%
287,829
+4,111
+1% +$10K
KRRO icon
2628
Korro Bio
KRRO
$195M
$639K ﹤0.01%
717
+11
+2% +$11.9K
BDTX icon
2629
Black Diamond Therapeutics
BDTX
$112M
$638K ﹤0.01%
+25,553
New +$778K
CASA
2630
DELISTED
Casa Systems, Inc. Common Stock
CASA
$636K ﹤0.01%
181,652
+2,614
+1% +$9.47K
CRAI icon
2631
CRA International
CRAI
$1.09B
$634K ﹤0.01%
18,970
+135
+0.7% +$6.43K
RAPT
2632
DELISTED
RAPT Therapeutics
RAPT
$631K ﹤0.01%
3,704
+1,679
+83% +$382K
ACBI
2633
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$631K ﹤0.01%
53,099
-480
-0.9% -$8.06K
RIGL icon
2634
Rigel Pharmaceuticals
RIGL
$750M
$629K ﹤0.01%
40,310
-14
-0% -$298
WTBA icon
2635
West Bancorporation
WTBA
$485M
$629K ﹤0.01%
38,410
-1,171
-3% -$25.3K
TCRR
2636
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$629K ﹤0.01%
81,206
+1,786
+2% +$21.9K
CALA
2637
DELISTED
Calithera Biosciences, Inc
CALA
$629K ﹤0.01%
7,075
+939
+15% +$112K
CTSO icon
2638
Cytosorbents Corp
CTSO
$22.6M
$628K ﹤0.01%
81,181
ENZ
2639
DELISTED
Enzo Biochem, Inc.
ENZ
$628K ﹤0.01%
248,066
+3,463
+1% +$8.51K
CASI
2640
DELISTED
CASI Pharmaceuticals
CASI
$622K ﹤0.01%
30,489
+435
+1% +$10.4K
AKRX
2641
DELISTED
Akorn Inc
AKRX
$622K ﹤0.01%
1,107,629
+513,453
+86% +$595K
JCAP
2642
DELISTED
Jernigan Capital, Inc.
JCAP
$613K ﹤0.01%
55,891
+1,092
+2% +$19.2K
SNDX icon
2643
Syndax Pharmaceuticals
SNDX
$1.82B
$612K ﹤0.01%
55,758
+5,594
+11% +$52.5K
EVER icon
2644
EverQuote
EVER
$906M
$611K ﹤0.01%
23,246
NVEC icon
2645
NVE Corp
NVEC
$609M
$611K ﹤0.01%
11,732
+56
+0.5% +$3.66K
CCRN
2646
DELISTED
Cross Country Healthcare
CCRN
$609K ﹤0.01%
90,324
-113
-0.1% -$1.07K
ARA
2647
DELISTED
American Renal Associates Holdings, Inc
ARA
$609K ﹤0.01%
92,079
+1,758
+2% +$15.3K
BCEL
2648
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$604K ﹤0.01%
36,468
+22,725
+165% +$412K
VRTV
2649
DELISTED
VERITIV CORPORATION
VRTV
$603K ﹤0.01%
76,593
-330,357
-81% -$4.2M
NGVC icon
2650
Vitamin Cottage Natural Grocers
NGVC
$654M
$602K ﹤0.01%
70,681
-45,363
-39% -$390K

Similar funds

Charles Schwab's Q1 2020 Portfolio in Review

As of Q1 2020, Charles Schwab held 3,284 positions worth $170B, down 8.5% from $186B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab deployed $31.1B of net new capital in Q1 2020, opening 103 new positions and adding to 2,418 existing holdings. Its largest new stake was iShares MBS ETF: 10,382,066 shares worth $1.15B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Darden Restaurants, an estimated $41.9M trimmed.

  • Charles Schwab's largest Q1 2020 buy was iShares MBS ETF: 10,382,066 shares worth $1.15B.
  • Charles Schwab added most to ExxonMobil in Q1 2020, an estimated $605M increase.
  • Charles Schwab's biggest Q1 2020 reduction was Darden Restaurants, cutting an estimated $41.9M.
  • Charles Schwab fully exited Liberty Property Trust in Q1 2020, selling an estimated $139M.
  • Charles Schwab's ten largest holdings make up 17% of its $170B portfolio in Q1 2020.
  • Charles Schwab opened 103 new positions and closed 50 in Q1 2020.
  • Charles Schwab's portfolio value fell 8.5% quarter-over-quarter to $170B.

Based on Charles Schwab's 13F filing for Q1 2020, filed 15 May 2020.